A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia

To assure complete tumor removal, frozen section analysis is the most common procedure for intraoperative pathological assessment of resected tumor margins. However, during one operation, multiple biopsies may be sent for examination, but only few of them are made into cryosections because of the co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui Huang, Youpei Lin, Wenrui Ma, Jiannan Liu, Jing Han, Xiaoyi Hu, Meilin Tang, Shiqiang Yan, Mieradilijiang Abudupataer, Chenping Zhang, Qiang Gao, Weijia Zhang
Formato: article
Lenguaje:EN
Publicado: eLife Sciences Publications Ltd 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/726d1170cc6b4532a6f30685452d07c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:726d1170cc6b4532a6f30685452d07c1
record_format dspace
spelling oai:doaj.org-article:726d1170cc6b4532a6f30685452d07c12021-12-01T11:04:16ZA pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia10.7554/eLife.704712050-084Xe70471https://doaj.org/article/726d1170cc6b4532a6f30685452d07c12021-10-01T00:00:00Zhttps://elifesciences.org/articles/70471https://doaj.org/toc/2050-084XTo assure complete tumor removal, frozen section analysis is the most common procedure for intraoperative pathological assessment of resected tumor margins. However, during one operation, multiple biopsies may be sent for examination, but only few of them are made into cryosections because of the complex preparation protocols and time-consuming pathological analysis, which potentially increases the risk of overlooking tumor involvement. Here, we propose a fluorescence-based pre-screening strategy that allows high-throughput, convenient, and fast gross assessment of resected tumor margins. A dual-activatable cationic fluorescent molecular rotor was developed to specifically illuminate live tumor cells’ cytoplasm by emitting two different fluorescence signals in response to elevations in hypoxia-induced nitroreductase (a biochemical marker) and cytoplasmic viscosity (a biophysical marker), two characteristics of cancer cells. The ability of the fluorescent molecular rotor in detecting tumor cells was evaluated in mouse and human specimens of multiple tissues by comparing with hematoxylin and eosin staining. Importantly, the fluorescent molecular rotor achieved 100 % specificity in discriminating lung and liver cancers from normal tissue, allowing pre-screening of the tumor-free surgical margins and promoting clinical decision. Altogether, this type of fluorescent molecular rotor and the proposed strategy may serve as a new option to facilitate intraoperative assessment of resected tumor margins.Hui HuangYoupei LinWenrui MaJiannan LiuJing HanXiaoyi HuMeilin TangShiqiang YanMieradilijiang AbudupataerChenping ZhangQiang GaoWeijia ZhangeLife Sciences Publications Ltdarticlepre-screening strategyfluorescent molecular rotordual-activatablecytoplasmic viscosityhypoxiaMedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic pre-screening strategy
fluorescent molecular rotor
dual-activatable
cytoplasmic viscosity
hypoxia
Medicine
R
Science
Q
Biology (General)
QH301-705.5
spellingShingle pre-screening strategy
fluorescent molecular rotor
dual-activatable
cytoplasmic viscosity
hypoxia
Medicine
R
Science
Q
Biology (General)
QH301-705.5
Hui Huang
Youpei Lin
Wenrui Ma
Jiannan Liu
Jing Han
Xiaoyi Hu
Meilin Tang
Shiqiang Yan
Mieradilijiang Abudupataer
Chenping Zhang
Qiang Gao
Weijia Zhang
A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
description To assure complete tumor removal, frozen section analysis is the most common procedure for intraoperative pathological assessment of resected tumor margins. However, during one operation, multiple biopsies may be sent for examination, but only few of them are made into cryosections because of the complex preparation protocols and time-consuming pathological analysis, which potentially increases the risk of overlooking tumor involvement. Here, we propose a fluorescence-based pre-screening strategy that allows high-throughput, convenient, and fast gross assessment of resected tumor margins. A dual-activatable cationic fluorescent molecular rotor was developed to specifically illuminate live tumor cells’ cytoplasm by emitting two different fluorescence signals in response to elevations in hypoxia-induced nitroreductase (a biochemical marker) and cytoplasmic viscosity (a biophysical marker), two characteristics of cancer cells. The ability of the fluorescent molecular rotor in detecting tumor cells was evaluated in mouse and human specimens of multiple tissues by comparing with hematoxylin and eosin staining. Importantly, the fluorescent molecular rotor achieved 100 % specificity in discriminating lung and liver cancers from normal tissue, allowing pre-screening of the tumor-free surgical margins and promoting clinical decision. Altogether, this type of fluorescent molecular rotor and the proposed strategy may serve as a new option to facilitate intraoperative assessment of resected tumor margins.
format article
author Hui Huang
Youpei Lin
Wenrui Ma
Jiannan Liu
Jing Han
Xiaoyi Hu
Meilin Tang
Shiqiang Yan
Mieradilijiang Abudupataer
Chenping Zhang
Qiang Gao
Weijia Zhang
author_facet Hui Huang
Youpei Lin
Wenrui Ma
Jiannan Liu
Jing Han
Xiaoyi Hu
Meilin Tang
Shiqiang Yan
Mieradilijiang Abudupataer
Chenping Zhang
Qiang Gao
Weijia Zhang
author_sort Hui Huang
title A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
title_short A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
title_full A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
title_fullStr A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
title_full_unstemmed A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
title_sort pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
publisher eLife Sciences Publications Ltd
publishDate 2021
url https://doaj.org/article/726d1170cc6b4532a6f30685452d07c1
work_keys_str_mv AT huihuang aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT youpeilin aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT wenruima aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT jiannanliu aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT jinghan aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT xiaoyihu aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT meilintang aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT shiqiangyan aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT mieradilijiangabudupataer aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT chenpingzhang aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT qianggao aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT weijiazhang aprescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT huihuang prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT youpeilin prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT wenruima prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT jiannanliu prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT jinghan prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT xiaoyihu prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT meilintang prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT shiqiangyan prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT mieradilijiangabudupataer prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT chenpingzhang prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT qianggao prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
AT weijiazhang prescreeningstrategytoassessresectedtumormarginsbyimagingcytoplasmicviscosityandhypoxia
_version_ 1718405239762059264